NCT04993729View on ClinicalTrials.gov

Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)

PHASE3CompletedINTERVENTIONAL

Enrollment

853

Participants

Timeline

Start Date

July 21, 2021

Primary Completion Date

May 26, 2023

Study Completion Date

May 26, 2023

Conditions

Acute Mountain Sickness (AMS)

Interventions

DRUG

T89 capsule

"T89 capsule (trade name Dantonic®) is a botanical drug containing 75mg active substance which is the water extract of Danshen and Sanqi.~T89 capsules, p.o. TID."

DRUG

Placebo capsule

Placebo capsules, p.o. TID.

Trial Locations (3)

94143

Hypoxia Research Lab, UCSF Parnassus Campus, S-256, San Francisco

610032

Affiliated Hospital of Chengdu University of TCM, Chengdu

850000

Tibet Autonomous Region People's Hospital, Lhasa

All Listed Sponsors

lead

Tasly Pharmaceuticals, Inc.

INDUSTRY

NCT04993729 - Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS) | Biotech Hunter | Biotech Hunter